Literature DB >> 1620244

The force driving the extraneuronal transport mechanism for catecholamines (uptake2).

E Schömig1, J Babin-Ebell, H Russ, U Trendelenburg.   

Abstract

Recently, uptake2 was shown to exist in the clonal Caki-1 cell line. The aim of this study was two-fold: a) to determine, in Caki-1 cells, the intracellular fate of 3H-noradrenaline after its translocation by uptake2 and b) to analyse the force driving uptake2. Caki-1 cells have the characteristics of a "metabolizing system" in which the activity of catechol-O-methyl transferase (COMT) greatly exceeds that of monoamine oxidase (MAO). In all subsequent experiments these enzymes were inhibited. The determination of initial rates of uptake2 into Caki-1 cells at an extracellular pH between 6.9 and 7.9 indicated that the protonated species of 3H-noradrenaline is transported. Depolarization of Caki-1 cells (by three different procedures) inhibited the inward transport. Determination of the time course of the specific accumulation of 3H-noradrenaline in Caki-1 cells and of 3H-isoprenaline in the perfused rat heart (both mediated by uptake2) revealed that depolarization (by high K+) reduced the rate constant for inward transport (kIN) and increased that for outward movement (kOUT). Consequently, depolarization reduced the steady-state factor of accumulation. It is proposed that, as the protonated species of the substrates of uptake2 is transported, the membrane potential is likely to provide the driving force for uptake2. The fact that depolarization decreased kIN and increased kOUT agrees with this proposal, as do the magnitudes of the steady-state accumulation factors determined in Caki-1 cells and perfused rat heart.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1620244     DOI: 10.1007/bf00176622

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

2.  Dissociation constants and lipophilicity of catecholamines and related compounds.

Authors:  F Mack; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

3.  A comparative study of the properties of the catechol-O-methyltransferase inhibitors, U-0521 and tropolone acetamide, in rat perfused heart.

Authors:  L J Bryan; H Fleig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-02       Impact factor: 3.000

Review 4.  Transport of protons across membranes by weak acids.

Authors:  S G McLaughlin; J P Dilger
Journal:  Physiol Rev       Date:  1980-07       Impact factor: 37.312

5.  On the mechanism of barium induced diastolic depolarisation in isolated ventricular myocytes.

Authors:  F Valenzuela; M Vassalle
Journal:  Cardiovasc Res       Date:  1989-05       Impact factor: 10.787

6.  The membrane potential of vascular smooth muscle appears to modulate uptake2 of 3H-isoprenaline.

Authors:  U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

7.  Autoradiographic study of rat hearts perfused with 3H-isoprenaline.

Authors:  I Azevedo; H Bönisch; W Osswald; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-02       Impact factor: 3.000

8.  The substrate specificity of uptake2 in the rat heart.

Authors:  M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

9.  Modulation of uptake2 of 3H-(+/-)-isoprenaline by isoprenaline-induced depolarization of rat salivary gland cells.

Authors:  U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

10.  The acceleration of the extraneuronal efflux of 3H-(+/-)-isoprenaline induced by high extracellular potassium.

Authors:  M Grohmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

View more
  10 in total

1.  Evidence from guinea-pig trachealis that Uptake2 of isoprenaline is enhanced by hyperpolarization of the smooth muscle.

Authors:  L J Bryan-Lluka; H E Vuocolo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

2.  Release of noradrenaline from isolated rat tail artery induced by bafilomycin A1.

Authors:  V Palatý
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

3.  Characterization of catecholamine uptake2 in isolated cardiac myocytes.

Authors:  O O Obst; H Rose; H Kammermeier
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

4.  Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells.

Authors:  Dirk Gründemann; Ann-Cathrin Koschker; Christine Haag; Cornelius Honold; Tim Zimmermann; Edgar Schömig
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

5.  Pharmacokinetic and alpha 1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport.

Authors:  H Russ; B Friedgen; B Königs; C Schumacher; K H Graefe; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

6.  Effects of albumin sensitization and challenge of guinea pigs on uptake2 of isoprenaline in trachealis muscle.

Authors:  L J Bryan-Lluka; H E Vuocolo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

7.  The effects of (-)-cromakalim and glibenclamide on uptake2 in guinea-pig trachealis muscle.

Authors:  L J Bryan-Lluka; H E Vuocolo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

8.  Organic cation transporter mRNA and function in the rat superior cervical ganglion.

Authors:  Doris Kristufek; Walter Rudorfer; Christian Pifl; Sigismund Huck
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

9.  Extraneuronal uptake of noradrenaline in human tissue (uptake2).

Authors:  J Babin-Ebell; M Gliese
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

10.  The extraneuronal transport mechanism for noradrenaline (uptake2) avidly transports 1-methyl-4-phenylpyridinium (MPP+).

Authors:  H Russ; M Gliese; J Sonna; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.